Friday 14 December 2018
Home      All news      Contact us     
reuters - 9 days ago

Takeda clears key hurdle as investors back $59 billion Shire deal

Takeda Pharmaceutical has won shareholder approval for its $59 billion takeover of London-listed Shire , creating a global powerhouse that has a stronger drugs pipeline but is also saddled with massive debt.

Related news

Latest News
Hashtags:   

Takeda

 | 

clears

 | 

hurdle

 | 

investors

 | 

billion

 | 

Shire

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Sources